本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apogee Therapeutics

72.31
+3.815.56%
盤後72.310.00000.00%16:55 EST
成交量:135.92萬
成交額:9,809.47萬
市值:50.24億
市盈率:-17.15
高:74.09
開:70.30
低:69.35
收:68.50
52周最高:84.56
52周最低:26.20
股本:6,948.52萬
流通股本:5,245.49萬
量比:1.64
換手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):-4.2155
每股收益(LYR):-4.2155
淨資產收益率:-31.57%
總資產收益率:-21.11%
市淨率:5.56
市盈率(LYR):-17.15

資料載入中...

2026/03/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/10

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]